| A novel cationic niosome formulation for gene delivery to the retina G Puras, M Mashal, J Zárate, M Agirre, E Ojeda, S Grijalvo, R Eritja, ... Journal of Controlled Release 174, 27-36, 2014 | 129 | 2014 |
| Retinal gene delivery enhancement by lycopene incorporation into cationic niosomes based on DOTMA and polysorbate 60 M Mashal, N Attia, G Puras, G Martínez-Navarrete, E Fernández, ... Journal of controlled release 254, 55-64, 2017 | 47 | 2017 |
| Cationic niosomes as non-viral vehicles for nucleic acids: Challenges and opportunities in gene delivery S Grijalvo, G Puras, J Zárate, M Sainz-Ramos, NAL Qtaish, T López, ... Pharmaceutics 11 (2), 50, 2019 | 45 | 2019 |
| Stem cell-based gene delivery mediated by cationic niosomes for bone regeneration N Attia, M Mashal, S Grijalvo, R Eritja, J Zárate, G Puras, JL Pedraz Nanomedicine: Nanotechnology, Biology and Medicine 14 (2), 521-531, 2018 | 37 | 2018 |
| Protamine/DNA/niosome ternary nonviral vectors for gene delivery to the retina: the role of protamine G Puras, G Martínez-Navarrete, M Mashal, J Zarate, M Agirre, E Ojeda, ... Molecular Pharmaceutics 12 (10), 3658-3671, 2015 | 35 | 2015 |
| Gene delivery to the rat retina by non-viral vectors based on chloroquine-containing cationic niosomes M Mashal, N Attia, G Martínez-Navarrete, C Soto-Sánchez, E Fernández, ... Journal of Controlled Release 304, 181-190, 2019 | 31 | 2019 |
| Non-viral vectors based on cationic niosomes as efficient gene delivery vehicles to central nervous system cells into the brain M Mashal, N Attia, C Soto-Sánchez, G Martínez-Navarrete, E Fernández, ... International journal of pharmaceutics 552 (1-2), 48-55, 2018 | 25 | 2018 |
| Elaboration and physicochemical characterization of niosome-based nioplexes for gene delivery purposes E Ojeda, M Agirre, I Villate-Beitia, M Mashal, G Puras, J Zarate, JL Pedraz Non-Viral Gene Delivery Vectors, 63-75, 2016 | 15 | 2016 |
| Gene transfer to rat cerebral cortex mediated by polysorbate 80 and poloxamer 188 nonionic surfactant vesicles N Attia, M Mashal, C Soto-Sánchez, G Martinez-Navarrete, E Fernández, ... Drug design, development and therapy 12, 3937, 2018 | 12 | 2018 |
| Mesenchymal stem cells: the past present and future N Attia, M Mashal Cell Biology and Translational Medicine, Volume 11, 107-129, 2020 | 10 | 2020 |
| Cationic niosome-based hBMP7 gene transfection of neuronal precursor NT2 cells to reduce the migration of glioma cells in vitro N Attia, M Mashal, S Grijalvo, R Eritja, G Puras, JL Pedraz Journal of Drug Delivery Science and Technology 53, 101219, 2019 | 7 | 2019 |
| Mesenchymal stem cells as a gene delivery tool: Promise, problems, and prospects N Attia, M Mashal, G Puras, JL Pedraz Pharmaceutics 13 (6), 843, 2021 | 5 | 2021 |
| Mesenchymal stem cells versus their extracellular vesicles in treatment of liver fibrosis: Is it possible to compare? N Attia, YH Khalifa, DM Rostom, M Mashal Medical Research Archives 9 (2), 2021 | 3 | 2021 |
| Insights into the potential role of alpha1‐antitrypsin in COVID‐19 patients: Mechanisms, current update, and future perspectives S Marzouk, N Attia, M Mashal The Clinical Respiratory Journal 15 (9), 1019-1024, 2021 | 2 | 2021 |
| The use of cerium oxide nanoparticles in liver disorders: A double‐sided coin? N Attia, DM Rostom, M Mashal Basic & Clinical Pharmacology & Toxicology 130 (3), 349-363, 2022 | 1 | 2022 |
| Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies N Attia, M Mashal, S Pemminati, A Omole, C Edmondson, W Jones, ... Cells 11 (1), 116, 2021 | 1 | 2021 |
| Design, elaboration, characterization and evaluation of niosome formulations for gene delivery to retina and brain MAA Mashal Universidad del País Vasco-Euskal Herriko Unibertsitatea, 2020 | | 2020 |
Jose Luis PedrazProfessor of Pharmaceutical Technology. Universidad Pais Vasco (UPV/EHU)E-mail megerősítve itt: ehu.eus
